NCT03121040

Brief Summary

ATP is generated mainly through anaerobic metabolism during strenuous exercise, which is then followed by the generation of lactic acid. However, this process can only be maintained for a short time, approximately one minute, because the accumulation of lactic acid in the muscles may affect muscle performance. The efficiency of lactic acid metabolism is one of the most important reasons for endurance improvement. The purpose of this study was to evaluate the impacts of the daily ingestion of a commercially available Vespa amino acid mixture (VAAM®) beverage on blood parameters that are related to fatigue, muscle damage and immunity in healthy, young athletes during middle-distance running exercises. VAAM® contains 17 types of amino acids at a certain ratio, and evaluations were completed during 10 weeks of consecutive required speed and strength running tests.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2009

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2009

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2009

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2009

Completed
7.7 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2017

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 19, 2017

Completed
Last Updated

April 19, 2017

Status Verified

April 1, 2017

Enrollment Period

3 months

First QC Date

April 1, 2017

Last Update Submit

April 18, 2017

Conditions

Keywords

Vespa amino acid mixture (VAAM®)Young athletesNutritionlactic acid accumulationAnaerobic metabolismATPSports damage

Outcome Measures

Primary Outcomes (3)

  • change of running time scores at 10 weeks

    10 weeks

  • change of the plasma lactic acid clearance rate after running at 10 weeks

    10 weeks

  • change of red blood cells after running at 10 weeks

    10 weeks

Study Arms (3)

Subjects ingested VAAM® for 10 weeks

EXPERIMENTAL

Ten young athletes ingested Vespa amino acid mixture (VAAM®) for 10 weeks, divided into different meter race including 1500-, 800- and 400-meter races.

Dietary Supplement: Vespa amino acid mixture

Subjects ingested VAAM® for 6 weeks

EXPERIMENTAL

Ten young athletes ingested Vespa amino acid mixture (VAAM®) for 6 weeks, divided into different meter race including 1500-, 800- and 400-meter races.

Dietary Supplement: Vespa amino acid mixture

Subjects ingested nothing

NO INTERVENTION

Ten young athletes before ingesting Vespa amino acid mixture (VAAM®) , divided into different meter race including 1500-, 800- and 400-meter races.

Interventions

Vespa amino acid mixtureDIETARY_SUPPLEMENT

17 kinds of amino acids mixture in specific proportion

Also known as: VAAM®
Subjects ingested VAAM® for 10 weeksSubjects ingested VAAM® for 6 weeks

Eligibility Criteria

Age16 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Athletes from 16 to 18 years old;
  • Subjects underwent a physical examination before enrollment and showed no sign of illness or malaise.

You may not qualify if:

  • Subjects were smokers or ergogenic aid users;
  • Subjects had any metabolic, cardiovascular, renal, or liver diseases;
  • Subjects had psychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Athletic Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2017

First Posted

April 19, 2017

Study Start

May 2, 2009

Primary Completion

July 16, 2009

Study Completion

July 22, 2009

Last Updated

April 19, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share